Myocardial infarction and stroke risks in multiple sclerosis patients: A two-sample Mendelian randomization study

Mult Scler Relat Disord. 2022 Feb:58:103501. doi: 10.1016/j.msard.2022.103501. Epub 2022 Jan 6.

Abstract

Observational studies indicated multiple sclerosis (MS) patients may have a higher risk of myocardial infarction (MI) and stroke than the general population, whereas the previously reported findings were inconsistent. Using two-sample Mendelian randomization (MR) analysis with genetic data from large-scale genome-wide association studies (International Multiple Sclerosis Genetics Consortium containing 14,498 MS cases, Coronary ARtery DIsease Genome wide Replication and Meta-analysis plus The Coronary Artery Disease Genetics consortium containing 43,676 MI cases and 40,585 stroke cases), we found that MS was causally associated with an increased risk of MI (OR = 1.03; 95%CI 1.00-1.06; P = 0.0243), directionally consistent in the weighted median, MR-Egger, and the MR-PRESSO methods. No causal association between MS and stroke was observed (OR = 1.01; 95%CI 0.99-1.04; P = 0.2974). Therefore, timelier and more effective measures should be conducted among MS patients to decrease the burden of both diseases.

Keywords: Causality; Mendelian randomization analysis; Multiple sclerosis; Myocardial infarction; Stroke.

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Genome-Wide Association Study
  • Humans
  • Mendelian Randomization Analysis
  • Multiple Sclerosis* / epidemiology
  • Multiple Sclerosis* / genetics
  • Myocardial Infarction* / epidemiology
  • Myocardial Infarction* / genetics
  • Polymorphism, Single Nucleotide
  • Stroke* / etiology
  • Stroke* / genetics